These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14269)

  • 61. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro.
    Siberry GK; Tekle T; Carroll K; Dick J
    Clin Infect Dis; 2003 Nov; 37(9):1257-60. PubMed ID: 14557972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical experience with clindamycin-2-phosphate in dermatological infections (author's transl)].
    Otaki N; Kagawa
    Jpn J Antibiot; 1977 Feb; 30(2):169-73. PubMed ID: 853575
    [No Abstract]   [Full Text] [Related]  

  • 63. Clindamycin-resistance in methicillin-resistant Staphylococcus aureus isolated from animals.
    Rich M; Deighton L; Roberts L
    Vet Microbiol; 2005 Dec; 111(3-4):237-40. PubMed ID: 16289541
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Studies on clindamycin-2-phosphate (author's transl)].
    Soejima R; Naoe H; Matsushima T; Tano Y; Kobayashi T
    Jpn J Antibiot; 1977 Feb; 30(2):161-5. PubMed ID: 853573
    [No Abstract]   [Full Text] [Related]  

  • 65. Linezolid for tympanostomy tube otorrhea caused by methicillin-resistant Staphylococcus aureus and multiple drug-resistant Streptococcus pneumoniae.
    Isaacson G; Aronoff SC
    Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):647-51. PubMed ID: 18321598
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Experience with clindamycin-2-palmitate in some acute pediatric infections (author's transl)].
    Hori M; Kono S; Aoki Y
    Jpn J Antibiot; 1973 Aug; 26(4):350-5. PubMed ID: 4542671
    [No Abstract]   [Full Text] [Related]  

  • 67. [Clinical application of clindamycin-2-phosphate to otorhinolaryngological infections (author's transl)].
    Baba S; Wada K; Naito M; Hondo J; Fukuoka Y
    Jpn J Antibiot; 1977 May; 30(5):341-5. PubMed ID: 266632
    [No Abstract]   [Full Text] [Related]  

  • 68. [Absorption and excretion as well as clinical evaluation of clindamycin-2-palmitate in pediatric field (author's transl)].
    Sato H; Oka S; Watanabe O; Nakazawa S; Murata B
    Jpn J Antibiot; 1973 Aug; 26(4):343-9. PubMed ID: 4542670
    [No Abstract]   [Full Text] [Related]  

  • 69. Treatment of Bacteroides infection with clindamycin-2-phosphate.
    Dickinson PC; Saphyakhajon P
    Can Med Assoc J; 1974 Nov; 111(9):945-7, 949. PubMed ID: 4609237
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Constitutive and inducible clindamycin resistance among nosocomially acquired staphylococci].
    Dizbay M; Günal O; Ozkan Y; Ozcan Kanat D; Altunçekiç A; Arman D
    Mikrobiyol Bul; 2008 Apr; 42(2):217-21. PubMed ID: 18697419
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Local application of neomycin in surface infections of the eye].
    Ernyei S
    Klin Monbl Augenheilkd; 1967; 150(6):887-9. PubMed ID: 5589909
    [No Abstract]   [Full Text] [Related]  

  • 73. Pharmacokinetics of clindamycin phosphate in dogs after single intravenous and intramuscular administrations.
    Budsberg SC; Kemp DT; Wolski N
    Am J Vet Res; 1992 Dec; 53(12):2333-6. PubMed ID: 1476318
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
    Sader HS; Flamm RK; Farrell DJ; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inducible clindamycin resistance in Staphylococcus aureus: a study from North India.
    Gupta V; Datta P; Rani H; Chander J
    J Postgrad Med; 2009; 55(3):176-9. PubMed ID: 19884741
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus.
    Liaqat F; Sheikh AA; Nazir J; Hussain T; Rabbani M; Shaheen AY; Muhammad J
    Pak J Pharm Sci; 2015 May; 28(3):997-1004. PubMed ID: 26004734
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Panton-Valentine leucocidin expression by Staphylococcus aureus exposed to common antibiotics.
    Turner CE; Sriskandan S
    J Infect; 2015 Sep; 71(3):338-46. PubMed ID: 26028260
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Penetration into bone and tissues of clindamycin phosphate.
    Baird P; Hughes S; Sullivan M; Willmot I
    Postgrad Med J; 1978 Feb; 54(628):65-7. PubMed ID: 634877
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clindamycin-2-phosphate in the treatment of respiratory infections and its distribution into pleural effusion].
    Takamoto M; Harada S; Harada Y; Kitahara Y; Kawahara M; Ishibashi T; Shinoda A
    Jpn J Antibiot; 1987 Apr; 40(4):727-34. PubMed ID: 3613089
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Experience in clinical application of clindamycin-2-phosphate (author's transl)].
    Okubo H; Okamoto Y; Go K; Uba F; Ueda Y
    Jpn J Antibiot; 1977 Feb; 30(2):156-60. PubMed ID: 853572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.